Nasal mucosal endorgan hyperresponsiveness

American Journal of Rhinology

Volumn 12, Issue 1, 1998, Pages 37-43

  Svensson, Christer ^a   Andersson, Morgan ^a   Greift, Lennart ^a   Persson, Carl G A ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALPHA 2 MACROGLOBULIN; ANTIHISTAMINIC AGENT; BRADYKININ; CAPSAICIN; DESMOPRESSIN; EDETATE CHROMIUM CR 51; FIBRINOGEN; HISTAMINE; METHACHOLINE; NICOTINE; PLASMA PROTEIN; STEROID;

ALLERGIC RHINITIS; COMMON COLD; CONFERENCE PAPER; EOSINOPHIL; EXUDATE; HUMAN; INFLAMMATION; LAMINA PROPRIA; NOSE MUCOSA; ORAL DRUG ADMINISTRATION; PERMEABILITY BARRIER; PROVOCATION TEST; TOPICAL DRUG ADMINISTRATION; VIRUS INFECTION;

EID: 0031921514     PISSN: 10506586     EISSN: None     Source Type: Journal    
DOI: 10.2500/105065898782103016     Document Type: Conference Paper

References (43)

1. Hilberg O, Jackson AC, Swift DL, Pedersen OF. Acoustic rhinometry: Evaluation of nasal cavity by acoustic reflections. J Appl Physiol 66:295-303, 1989.
2. Juto J-E, Lundberg C. An optical method for determining changes in mucosal congestion in the nose in man. Acta Otolaryngol (Stockh) 94:149-156, 1982.
3. Persson CGA, Svensson C, Greiff L, Andersson M, et al. The use of the nose to study the inflammatory response of the respiratory tract (editorial). Thorax 47:993-1000, 1992.
4. Borum P. Nasal methacholine test. A measurement of nasal reactivity. J Allergy Clin Immunol 63:253-257, 1979.
5. Brofeldt S, Mygind N, Sørensen CH, et al. Biochemical analysis of nasal secretions induced by methacholine, histamine and allergen provocations. Am Rev Respir Dis 133:1138-1142, 1986.
6. Raphael GD, Druce HM, Baraniuk JN, Kaliner M. Pathophysiology of rhinitis. 1. Assessment of the sources of protein in methacholine-induced nasal secretions. Am Rev Respir Dis 138:413-420, 1988.
7. Greiff L, Wollmer P, Erjefält I, Andersson M, Pipkorn U, Persson CGA. Effects of nicotine on the human nasal mucosa. Thorax 48:651-655, 1993.
8. Klementsson H, Andersson M, Baumgarten CR, et al. Changes in non-specific nasal reactivity and eosinophil influx and activation after allergen challenge. Clin Exp Allergy 20:539-547, 1990.
9. Klementsson H, Svensson C, Andersson M, et al. Eosinophils, secretory responsiveness and glucocorticoid-induced effects on the allergic nasal mucosa during a weak pollen season. Clin Exp Allergy 21:705-710, 1991.
10. Klementsson H, Andersson M, Venge P, Pipkorn U. Allergen-induced changes in nasal secretory responsiveness and eosinophil granulocytes. Acta Otolaryngol (Stockh) 111:776-784, 1991.
11. Klementsson H, Andersson M, Pipkorn U. Allergen-induced increase in non-specific nasal reactivity is blocked by antihistamines without a clearcut relationship to eosinophil influx. J Allergy Clin Immunol 86:466-472, 1990.
12. Greiff L, Svensson C, Andersson M, Persson CGA. Effects of topical capsaicin in seasonal allergic rhinitis. Thorax 50:225-229, 1995.
13. Greiff L, Pipkorn U, Alkner U, Persson CGA. The "nasal pool" device applies controlled concentrations of solutes on human nasal airway mucosa and samples its surface exudations/secretions. Clin Exp Allergy 20:253-259, 1990.
14. Persson CGA, Andersson M, Greiff L, Svensson C, et al. Airway permeability. Clin Exp Allergy 23:807-814, 1995.
15. Erjefält JS, Erjefält I, Sundler F, Persson CGA. Epithelial pathways for luminal entry of bulk plasma. Clin Exp Allergy 25:187-195, 1995.
16. Luts A, Sundler F, Erjefält I, Persson CGA. The airway epithelial lining in guinea pig is intact promptly after the mucosal crossing of a large amount of plasma exudate. Int Arch Allergy Appl Immunol 91:385-388, 1990.
17. 51Cr-EDTA across the human nasal mucosa in the presence of topical histamine. Thorax 46:630-632, 1991.
18. Erjefält I, Persson CGA. Allergen, bradykinin, and capsaicin increase outward but not inward macromolecular permeability of guinea-pig tracheobronchial mucosa. Clin Exp Allergy 21:217-224, 1991.
19. Persson CGA, Erjefält I, Gustafsson B, Luts A. Subepithelial hydrostatic pressure may regulate plasma exudation across the mucosa. Int Arch Allergy Appl Immunol 92:148-153, 1990.
20. Gustafsson B, Persson CGA. Asymmetrical effects of increases in hydrostatic pressure on macromolecular movement across the airway mucosa. A study in guinea-pig tracheal tube preparations. Clin Exp Allergy 21:121-126, 1991.
21. Svensson C, Alkner U, Pipkorn U, Persson CGA. Histamine-induced airway mucosal exudation of bulk plasma and plasma-derived mediators is not inhibited by intravenous bronchodilators. Eur J Clin Pharmacol 46:59-65, 1994.
22. 2-macroglobulin and tryptase into human nasal and bronchial airways. J Allergy Clin Immunol 96:239-246, 1995.
23. Svensson C, Baumgarten CR, Pipkorn U, Alkner U, Persson CGA. Reversibility and reproducibility of histamine induced plasma leakage in nasal airways. Thorax 44:13-18, 1989.
24. Proud D, Reynolds CJ, Lacapra S, et al. Nasal provocation with bradykinin induces symptoms of rhinitis and a sore throat. Am Rev Respir Dis 137:613-616, 1988.
25. Rajakulasingam K, Polosa R, Lau LCK, et al. Nasal effects of bradykinin and capsaicin: Influence on plasma protein leakage and role of sensory neurons. J Appl Physiol 72:1418-1424, 1992.
26. 4-, and histamine-induced mucosal exudation of plasma in human airways in vivo (abstract). Allergy Clin Immunol News suppl 2:85, 1994.
27. Svensson C, Andersson M, Persson CGA, et al. Albumin, bradykinins and eosinophil cationic protein on the nasal mucosa surface in hay fever patients during natural allergen exposure. J Allergy Clin Immunol 85:828-833, 1990.
28. Åkerlund A, Greiff L, Andersson M, Bende M, Alkner U, Persson CGA. Mucosal exudation of fibrinogen in coronavirus-induced common cold. Acta Otolaryngol (Stockh) 113:642-648, 1993.
29. Bascom R, Kagey-Sobotka A, Proud D. Effect of intranasal capsaicin on symptoms and mediator release. J Pharmacol Exp Ther 259:1323-1327, 1991.
30. Persson CGA, Erjefält I, Alkner U, Baumgarten CR, Greiff L, Gustafsson B, Luts A, Pipkorn U, Sundler U, Svensson C, Wollmer P. Plasma exudation as a first line respiratory mucosal defence. Clin Exp Allergy 21:17-24, 1991.
31. Erjefält JS, Erjefält I, Sundler F, Persson CGA. Microcirculation-derived factors in epithelial repair in vivo. Microvasc Res 48:161-178, 1994.
32. Erjefält JS, Erjefält I, Sundler F, Persson CGA. In vivo restitu-tion of the airway epithelium. Cell Tissue Res 281:305-316, 1995.
33. Persson CGA. Role of plasma exudation in asthmatic airways. Lancet 15:1126-1129, 1986.
34. Persson CGA. In vivo veritas: The continuing importance of discoveries in complex biosystems. Thorax 51:441-443, 1996.
35. Svensson C, Andersson M, Greiff L, Alkner U, Persson CGA. Exudative hyperresponsiveness of the airway microcirculation in seasonal allergic rhinitis. Clin Exp Allergy 25:942-950, 1995.
36. Greiff L, Andersson M, Åkerlund A, Wollmer P, Svensson C, Alkner U, Persson CGA. Microvascular exudative hyperresponsiveness in human coronavirus-induced common cold. Thorax 49:121-127, 1994.
37. Linden M, Greiff L, Andersson M, Svensson C, Åkerlund A, Bende M, Andersson E, Persson CGA. Nasal cytokines in common cold and allergic rhinitis. Clin Exp Allergy 25:166-172, 1995.
38. Greiff L, Wollmer P, Svensson C, Andersson M, Persson CGA. Effect of seasonal allergic rhinitis on airway mucosal absorption of chromium-51 labelled EDTA. Thorax 48:648-650, 1993.
39. Greiff L, Lundin S, Svensson C, Andersson M, Erjefält JS, Wollmer P, Persson CGA. Peptide absorption in human allergic airways (abstract). Eur Respir J 8 (suppl 19): 124s, 1995.
40. Erjefält JS, Erjefält I, Sundler F, Persson CGA. Mucosal nitric oxide may tonically suppress airways plasma exudation. Am J Respir Crit Care Med 150:227-232, 1994.
41. Greiff L, Andersson M, Svensson C, Nilsson M, Erjefält I, Erjefält JS, Persson CGA. Topical nitroprusside may reduce histamine-induced plasma exudation in human nasal airways. Allergy 50:593-597, 1995.
42. Bende M. The effect of topical decongestant on blood flow in normal and infected nasal mucosa. Acta Otolaryngol (Stockh) 96:523-527, 1983.
43. Svensson C, Pipkorn U, Alkner U, Baumgarten CR, Persson CGA. Topical vasoconstrictor (oxymetazoline) does not affect histamine-induced mucosal exudation of plasma in human nasal airways. Clin Exp Allergy 22:411-416, 1992.